Calculations of the rates of disassociation between small molecules and proteins have numerous applications, including assisting rapid discovery and testing of novel drugs. Free energy calculations consider the enthalpy and entropy of the full protein-ligand-water system and so have the potential to be more accurate than faster, single-point calculations. In this study, methods are explored to predict the binding affinity of various molecules to proteins by molecular dynamics and umbrella sampling. An attempt was made to determine the potential of mean force (PMF) for the molecule, which was compared to its known binding capability. Factors including simulation resources, amounts of sampling, force strength parameters, and correlation betwe...
Molecular recognition is the basis of biological mechanisms and is a key element to consider while f...
Computational studies play an increasingly important role in chemistry and biophysics, mainly thanks...
The early stages of drug design rely on hit discovery programs, where initial possible inhibitors’ b...
Calculations of the rates of disassociation between small molecules and proteins have numerous appli...
Predicting drug efficacy with computational tools remains one of the major challenges in drug discov...
Biomolecular simulations have been widely used in the study of protein-ligand interactions; comprehe...
Protein-ligand binding free energy is one of the keystones of drug design, and developing a fast met...
In the drug discovery process, accurate methods of computing the affinity of small molecules with a ...
Designing tight-binding ligands is a primary objective of small-molecule drug discovery. Over the pa...
Many limitations of current computer-aided drug design arise from the difficulty of reliably predict...
Accurate methods of computing the affinity of ligand with protein target are strongly needed in the ...
Computational capabilities are rapidly increasing, primarily because of the availability of GPU-base...
Free energy calculations based on molecular dynamics simulations show considerable promise for appli...
Nowadays, drug design projects benefit from highly accurate protein−ligand binding free energy predi...
Designing tight-binding ligands is a primary objective of small-molecule drug discovery. Over the pa...
Molecular recognition is the basis of biological mechanisms and is a key element to consider while f...
Computational studies play an increasingly important role in chemistry and biophysics, mainly thanks...
The early stages of drug design rely on hit discovery programs, where initial possible inhibitors’ b...
Calculations of the rates of disassociation between small molecules and proteins have numerous appli...
Predicting drug efficacy with computational tools remains one of the major challenges in drug discov...
Biomolecular simulations have been widely used in the study of protein-ligand interactions; comprehe...
Protein-ligand binding free energy is one of the keystones of drug design, and developing a fast met...
In the drug discovery process, accurate methods of computing the affinity of small molecules with a ...
Designing tight-binding ligands is a primary objective of small-molecule drug discovery. Over the pa...
Many limitations of current computer-aided drug design arise from the difficulty of reliably predict...
Accurate methods of computing the affinity of ligand with protein target are strongly needed in the ...
Computational capabilities are rapidly increasing, primarily because of the availability of GPU-base...
Free energy calculations based on molecular dynamics simulations show considerable promise for appli...
Nowadays, drug design projects benefit from highly accurate protein−ligand binding free energy predi...
Designing tight-binding ligands is a primary objective of small-molecule drug discovery. Over the pa...
Molecular recognition is the basis of biological mechanisms and is a key element to consider while f...
Computational studies play an increasingly important role in chemistry and biophysics, mainly thanks...
The early stages of drug design rely on hit discovery programs, where initial possible inhibitors’ b...